XG-102 administered to healthy male volunteers as a single intravenous infusion: a randomized, double-blind, placebo-controlled, dose-escalating study

The aim of the study is to evaluate the safety, tolerability and pharmacokinetics (PK) of the JNK inhibitor XG-102 in a randomized, double blind, placebo controlled, sequential ascending dose parallel group Phase 1 Study. Three groups of male subjects received as randomly assigned ascending single X...

Descripción completa

Detalles Bibliográficos
Autores principales: Deloche, Catherine, Lopez-Lazaro, Luis, Mouz, Sébastien, Perino, Julien, Abadie, Claire, Combette, Jean-Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186400/
https://www.ncbi.nlm.nih.gov/pubmed/25505576
http://dx.doi.org/10.1002/prp2.20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186400/
https://www.ncbi.nlm.nih.gov/pubmed/25505576
http://dx.doi.org/10.1002/prp2.20

Ejemplares similares